{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:45:05Z","timestamp":1790707505134,"version":"4.1.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T00:00:00Z","timestamp":1447113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0142456","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T14:17:51Z","timestamp":1447165071000},"page":"e0142456","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["TAK-242, a Toll-Like Receptor 4 Antagonist, Protects against Aldosterone-Induced Cardiac and Renal Injury"],"prefix":"10.1371","volume":"10","author":[{"given":"Yide","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weisheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houyong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,11,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrneph.2013.110","article-title":"Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis","volume":"9","author":"NJ Brown","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"F833","DOI":"10.1152\/ajprenal.00557.2010","article-title":"Osteopontin deficiency protects against aldosterone-induced inflammation, oxidative stress, and interstitial fibrosis in the kidney","volume":"301","author":"J Irita","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"B Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.amjcard.2004.01.007","article-title":"Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension","volume":"93","author":"GH Williams","year":"2004","journal-title":"Am J Cardiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/01.HYP.0000067463.13172.EA","article-title":"Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension","volume":"41","author":"WB White","year":"2003","journal-title":"Hypertension"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/HJH.0b013e3280112ce5","article-title":"Interactions between aldosterone and connective tissue growth factor in vascular and renal damage in spontaneously hypertensive rats","volume":"25","author":"N de las Heras","year":"2007","journal-title":"J Hypertens"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1523-1755.2000.00277.x","article-title":"Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo","volume":"58","author":"NJ Brown","year":"2000","journal-title":"Kidney Int"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jphs.10R07CR","article-title":"Pathophysiological roles of aldosterone and mineralocorticoid receptor in the kidney","volume":"115","author":"K Rafiq","year":"2011","journal-title":"J Pharmacol Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5414\/CN107875","article-title":"The role of renal damage on cardiac remodeling in patients with diabetic nephropathy","volume":"80","author":"YD Zhang","year":"2013","journal-title":"Clin Nephrol"},{"key":"ref10","first-page":"152","article-title":"Inflammation in hypertension","volume":"15","author":"C Savoia","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.mehy.2004.10.016","article-title":"Inflammation may be a bridge connecting hypertension and atherosclerosis","volume":"64","author":"JJ Li","year":"2005","journal-title":"Med Hypotheses"},{"key":"ref12","first-page":"S22","article-title":"Mechanistic connection between inflammation and fibrosis","author":"SB Lee","year":"2010","journal-title":"Kidney Int Suppl"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrneph.2014.114","article-title":"Inflammatory processes in renal fibrosis","volume":"10","author":"XM Meng","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e93513","DOI":"10.1371\/journal.pone.0093513","article-title":"Mizoribine ameliorates renal injury and hypertension along with the attenuation of renal caspase-1 expression in aldosterone-salt-treated rats","volume":"9","author":"T Doi","year":"2014","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","article-title":"The inflammatory response in myocardial injury, repair, and remodelling","volume":"11","author":"NG Frangogiannis","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/j.jrn.2014.10.020","article-title":"Diabetic nephropathy and proximal tubular damage","volume":"25","author":"SC Tang","year":"2015","journal-title":"J Ren Nutr"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molimm.2014.11.003","article-title":"Renal expression of Toll-like receptor 2 and 4: dynamics in human allograft injury and comparison to rodents","volume":"64","author":"EG Stribos","year":"2015","journal-title":"Mol Immunol"},{"key":"ref18","article-title":"Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension","author":"R Hernanz","year":"2015","journal-title":"Br J Pharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.2353\/ajpath.2010.100153","article-title":"Toll-like receptor 9 enhances nephritogenic immunity and glomerular leukocyte recruitment, exacerbating experimental crescentic glomerulonephritis","volume":"177","author":"SA Summers","year":"2010","journal-title":"Am J Pathol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e94366","DOI":"10.1371\/journal.pone.0094366","article-title":"The early activation of toll-like receptor (TLR)-3 initiates kidney injury after ischemia and reperfusion","volume":"9","author":"P Paulus","year":"2014","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.matbio.2014.01.010","article-title":"Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury","volume":"35","author":"K Moreth","year":"2014","journal-title":"Matrix Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/cvr\/cvt118","article-title":"Adiponectin protects against Toll-like receptor 4-mediated cardiac inflammation and injury","volume":"99","author":"A Jenke","year":"2013","journal-title":"Cardiovasc Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/liv.12047","article-title":"Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis","volume":"33","author":"N Shah","year":"2013","journal-title":"Liver Int"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijcard.2015.03.190","article-title":"Anti-toll like receptor 4 (TLR4) therapy diminishes cardiac remodeling regardless of changes in blood pressure in spontaneously hypertensive rats (SHR)","volume":"187","author":"C Echem","year":"2015","journal-title":"Int J Cardiol"},{"key":"ref25","article-title":"Angiotensin Activates MCP-1 and Induces Cardiac Hypertrophy and Dysfunction via Toll-like Receptor 4","author":"S Matsuda","year":"2015","journal-title":"J Atheroscler Thromb"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/cvr\/cvu067","article-title":"Central blockade of TLR4 improves cardiac function and attenuates myocardial inflammation in angiotensin II-induced hypertension","volume":"103","author":"RB Dange","year":"2014","journal-title":"Cardiovasc Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/hr.2010.270","article-title":"Hypertension augments cardiac Toll-like receptor 4 expression and activity","volume":"34","author":"R Eissler","year":"2011","journal-title":"Hypertens Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cardiores.2005.05.025","article-title":"Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload","volume":"68","author":"T Ha","year":"2005","journal-title":"Cardiovasc Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/SHK.0b013e3181f48942","article-title":"Combination of imipenem and TAK-242, a Toll-like receptor 4 signal transduction inhibitor, improves survival in a murine model of polymicrobial sepsis","volume":"35","author":"T Sha","year":"2011","journal-title":"Shock"},{"key":"ref30","first-page":"23","article-title":"Toll-like receptor 4 mediates microglial activation and production of inflammatory mediators in neonatal rat brain following hypoxia: role of TLR4 in hypoxic microglia","volume":"10","author":"L Yao","year":"2013","journal-title":"J Neuroinflammation"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.HYP.0000029106.10586.4C","article-title":"Kidney specificity of rat chromosome 1 blood pressure quantitative trait locus region","volume":"40","author":"JR Clemitson","year":"2002","journal-title":"Hypertension"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"25221","DOI":"10.1074\/jbc.M110.116137","article-title":"miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop","volume":"285","author":"K Kapinas","year":"2010","journal-title":"J Biol Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1471-4906(02)02317-7","article-title":"Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses","volume":"23","author":"AA Beg","year":"2002","journal-title":"Trends Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0167-5273(02)00021-9","article-title":"Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension. Correlations with plasma endothelin-1","volume":"83","author":"JT Parissis","year":"2002","journal-title":"Int J Cardiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e0117757","DOI":"10.1371\/journal.pone.0117757","article-title":"Sorafenib ameliorates renal fibrosis through inhibition of TGF-beta-induced epithelial-mesenchymal transition","volume":"10","author":"L Jia","year":"2015","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1074\/jbc.M111.279836","article-title":"Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells","volume":"287","author":"V Masola","year":"2012","journal-title":"J Biol Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e34026","DOI":"10.1371\/journal.pone.0034026","article-title":"Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition","volume":"7","author":"CY Sun","year":"2012","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrneph.2010.30","article-title":"Aldosterone: effects on the kidney and cardiovascular system","volume":"6","author":"M Briet","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.107.098806","article-title":"Chemokine receptor 2b inhibition provides renal protection in angiotensin II\u2014salt hypertension","volume":"50","author":"AA Elmarakby","year":"2007","journal-title":"Hypertension"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.smim.2003.10.003","article-title":"TLR signaling pathways","volume":"16","author":"K Takeda","year":"2004","journal-title":"Semin Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"S Akira","year":"2006","journal-title":"Cell"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1681\/ASN.2008010123","article-title":"Tracking the toll of kidney disease","volume":"19","author":"AC Shirali","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature01326","article-title":"The immunopathogenesis of sepsis","volume":"420","author":"J Cohen","year":"2002","journal-title":"Nature"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.metabol.2010.01.005","article-title":"Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications","volume":"60","author":"S Devaraj","year":"2011","journal-title":"Metabolism"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/ATVBAHA.111.228924","article-title":"Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy","volume":"31","author":"S Devaraj","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jdiacomp.2014.07.003","article-title":"Global Toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy","volume":"28","author":"I Jialal","year":"2014","journal-title":"J Diabetes Complications"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-11-8","article-title":"Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress","volume":"11","author":"I Garate","year":"2014","journal-title":"J Neuroinflammation"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejphar.2007.06.027","article-title":"Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model","volume":"571","author":"T Sha","year":"2007","journal-title":"Eur J Pharmacol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0142456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T13:33:39Z","timestamp":1540215219000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0142456"}},"subtitle":[],"editor":[{"given":"Jaap A.","family":"Joles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,10]]},"references-count":48,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0142456","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,10]]}}}